medigraphic.com
ISSN 1405-8871 (Print)

2020, Number 3

<< Back Next >>

Aten Fam 2020; 27 (3)

Diagnostic Criteria from the American College of Cardiology/American Heart Association Hypertension 2017 in Mexico

Martínez MA

Language: Spanish
References: 23
Page: 155-158
PDF size: 113.00 Kb.


ABSTRACT

The American College of Cardiology/ American Heart Association Hypertension 2017 guide (ACC/AHA 2017) implemented more stringent diagnostic criteria and treatment goals for hypertension compared to other care guides, leading to various difficulties and questions for its application on a global scale. In Mexico, clinical practice guidelines and the Official Mexican Standard for the Diagnosis and Treatment of Arterial Hypertension to date do not include this new classification; this letter discusses the most important contributions of the ACC/AHA 2017 guide, in order to provide the Primary Care physician with elements that support a correct assessment of patients for timely diagnosis and proper management.


REFERENCES

  1. DOF - Diario Oficial de la Federación [Internet]. [Citado 9 de enero de 2020]. Disponible en: http://www.dof.gob.mx/nota_detalle.php?codigo= 5480159&fecha=19/04/2017

  2. Alberto Francisco Rubio-Guerra. Nuevas guías del American College of Cardiology/American Heart Association Hypertension para el tratamiento de la hipertensión. ¿Un salto en la dirección correcta? Med Interna México. 34(2).

  3. Cenetec [Internet]. [Citado 2020 ene 09]. Disponible en: http://www.cenetec.salud.gob.mx/ descargas/gpc/CatalogoMaestro/076-GCP__HipertArterial1NA/ HIPERTENSION_EVR_CENETEC. pdf

  4. Rubio Guerra AF, Garro Almendaro AK, Lozano Nuevo JJ, Arana Pazos KC, Duran Salgado MB, Morales López H. Prehypertension is associated with peripheral arterial disease and low ankle-brachial index. Indian Heart J. Julio. 2018;70(4):502- 5.

  5. Rubio Guerra AF, Arana Pazos KC, Lozano Nuevo JJ, Guerrero García C, Vargas Ayala G. Riesgo aumentado de trastornos metabólicos en prehipertensos. 2017;5.

  6. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. diciembre de 2002;360(9349):1903- 13.

  7. Mendoza Vázquez G, Espinoza Gómez F, Guzmán Silahua S, Nava Zavala AH. Prehipertensión arterial y su relación con factores de riesgo cardiovascular. 10.

  8. Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ ESH on Hypertension Guidelines. J Am Coll Cardiol. Junio. 2019;73(23):3018-26.

  9. Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial [Internet]. [Citado 2020 Ene 09]. Disponible en: https://www. revespcardiol.org/es-pdf-S0300893218306791

  10. Chobanian AV. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report. JAMA. 2003;289(19):2560.

  11. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017;71(6). ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Hypertension [Internet]. [Citado 2020 Ene 10]. Disponible en: https://www.ahajournals.org/doi/10.1161/ HYP.0000000000000065

  12. Gijón Conde T, Gorostidi M, Camafort M, Abad Cardiel M, Martín Rioboo E, Morales Olivas F, et al. Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial. Hipertens Riesgo Vasc. 2018;35(3):119-29.

  13. Ávila MH, Dommarco JR, Levy TS, Nasu LC, Acosta LMG, Pineda EBG, et al. Responsables de la ENSANUT MC 2016. 2016;149.

  14. Frankle RT. Nutrition education in the medical school curriculum: a proposal for action: a curriculum design. Am J Clin Nutr. 1976;29(1):105-9.

  15. Rosas Peralta M, Borrayo Sánchez G. Impacto de los nuevos criterios para diagnóstico y tratamiento de la hipertensión arterial sistémica sugeridos por la American College of Cardiology/American Heart Association. Gac México. 2018;154(6):1413.

  16. ASCVD Risk Estimator + [Internet]. [Citado 2020 Ene 12]. Disponible en: http://tools.acc.org/ ASCVD-Risk-Estimator-Plus/

  17. Goupil R, Lamarre Cliche M, Vallée M. The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications. Can J Cardiol. 2018;34(5):665-9.

  18. Arrúa Torreani N. New 2017 guidelines for the management of arterial hypertension. Rev Virtual Soc Paraguaya Med Interna. 2018;5(1):9-11.

  19. Kibria GMA, Swasey K, Choudhury A, Burrowes V, Stafford KA, Uddin SMI, et al. The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh. J Hum Hypertens. 2018;32(8-9):608-16.

  20. Skeete J, Connell K, Ordunez P, DiPette DJ. The American College of Cardiology/American Heart Association 2017 hypertension guideline: Implications for incorporation in Latin America, the Caribbean, and other resource-limited settings. J Clin Hypertens. 2018;20(9):1342-9.

  21. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137(2):109-18.

  22. Hernández Vásquez A, Rojas Roque C, Santero M, Ruiz Maza JC, Casas Bendezú M, Miranda JJ. ¿Qué representa cambiar el umbral diagnóstico de la hipertensión arterial? Guías ACC/AHA 2017 y su aplicación en Perú. Rev Médica Chile. 2019;147(5):545-56.

  23. Salinas Escudero G, Carrillo Vega MF, Pérez Zepeda MU, García Peña C. Gasto de bolsillo en salud durante el último año de vida de adultos mayores mexicanos: análisis del Enasem. Salud Pública México. 2019;61:504.




2020     |     www.medigraphic.com